Pharma-Bio Serv, Inc. Operating Income Loss

• Pharma-Bio Serv, Inc. showed an increase of +50.5% in Operating Income Loss from 2024 to 2025.
• This data is from Pharma-Bio Serv, Inc.'s annual report (Form 10-K), filed with the SEC on January 29, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), Pharma-Bio Serv, Inc.'s Operating Income Loss has declined by 204.6%.
• Historical annual values: Fiscal year 2025: -$637.7 thousand | Fiscal year 2024: -$1.29 million | Fiscal year 2023: $1.12 million | Fiscal year 2022: $1.17 million | Fiscal year 2021: -$3.85 million | Fiscal year 2020: $2.23 million | Fiscal year 2019: $1.70 million | Fiscal year 2018: -$1.26 million | Fiscal year 2017: -$777.8 thousand | Fiscal year 2016: -$91.8 thousand | Fiscal year 2015: $1.78 million | Fiscal year 2014: $2.86 million | Fiscal year 2013: $6.07 million | Fiscal year 2012: $5.73 million | Fiscal year 2011: $3.45 million | Fiscal year 2010: $609.9 thousand.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026